MedPath

CRITITECH, INC.

CRITITECH, INC. logo
🇺🇸United States
Ownership
Holding
Established
2001-01-01
Employees
11
Market Cap
-
Website
http://www.crititech.com

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers

Phase 1
Completed
Conditions
Peritoneal Neoplasms
Interventions
First Posted Date
2008-04-25
Last Posted Date
2014-02-27
Lead Sponsor
CritiTech, Inc.
Target Recruit Count
22
Registration Number
NCT00666991
Locations
🇺🇸

University of Kansas Medical Center, Kansas City, Kansas, United States

🇺🇸

Cancer Center of Kansas, Wichita, Kansas, United States

🇺🇸

Peggy and Charles Stephenson Oklahoma Cancer Center, Oklahoma City, Oklahoma, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.